Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Viral Transduction Enhancer Market Research Report 2025

Global Viral Transduction Enhancer Market Research Report 2025

Industry: Medical Devices & Consumables

Published Date: 2025-03-10

Pages: 89 Pages

Report ld: 4611503

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Viral Transduction Enhancer was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

A Viral Transduction Enhancer refers to a substance or method that increases the efficiency with which a virus introduces genetic material into a host cell. In gene therapy and research, viral transduction is a common technique used to deliver therapeutic genes or other genetic elements into cells. Enhancers in this context can include chemical compounds, modifications to the virus, or specific environmental conditions that improve the virus's ability to enter the host cell, thereby increasing the success rate of gene delivery and expression. These enhancers are crucial in optimizing the effectiveness of viral-based gene therapies and related biotechnological applications.

North American market for Viral Transduction Enhancer is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Viral Transduction Enhancer is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Viral Transduction Enhancer include Thermo Fisher Scientific, Applied Biological Materials, Takara Bio, OZ Biosciences, Revvity, Bio-Techne, Virongy, BPS Bioscience, System Biosciences, Miltenyi Biotec, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Viral Transduction Enhancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Transduction Enhancer.

The Viral Transduction Enhancer market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Viral Transduction Enhancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Viral Transduction Enhancer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Thermo Fisher Scientific

Applied Biological Materials

Takara Bio

OZ Biosciences

Revvity

Bio-Techne

Virongy

BPS Bioscience

System Biosciences

Miltenyi Biotec

komabiotech

ABP Biosciences

Segment by Type

Retrovirus (RV)

Adenovirus (AdV)

Adeno-associated Virus (AAV)

Segment by Application

Hospitals

Clinical Laboratories

Others

Consumption by Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East and Africa

Turkey

Saudi Arabia

UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Viral Transduction Enhancer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Viral Transduction Enhancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Viral Transduction Enhancer Market Overview

1.1 Product Definition

1.2 Viral Transduction Enhancer by Type

1.2.1 Global Viral Transduction Enhancer Market Value Comparison by Type (2024 VS 2031)

1.2.2 Retrovirus (RV)

1.2.3 Adenovirus (AdV)

1.2.4 Adeno-associated Virus (AAV)

1.3 Viral Transduction Enhancer by Application

1.3.1 Global Viral Transduction Enhancer Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Clinical Laboratories

1.3.4 Others

1.4 Global Viral Transduction Enhancer Market Size Estimates and Forecasts

1.4.1 Global Viral Transduction Enhancer Revenue 2020-2031

1.4.2 Global Viral Transduction Enhancer Sales 2020-2031

1.4.3 Global Viral Transduction Enhancer Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Viral Transduction Enhancer Market Competition by Manufacturers

2.1 Global Viral Transduction Enhancer Sales Market Share by Manufacturers (2020-2025)

2.2 Global Viral Transduction Enhancer Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Viral Transduction Enhancer Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Viral Transduction Enhancer, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Viral Transduction Enhancer, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Viral Transduction Enhancer, Product Type & Application

2.7 Global Key Manufacturers of Viral Transduction Enhancer, Date of Enter into This Industry

2.8 Global Viral Transduction Enhancer Market Competitive Situation and Trends

2.8.1 Global Viral Transduction Enhancer Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Viral Transduction Enhancer Players Market Share by Revenue

2.8.3 Global Viral Transduction Enhancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Viral Transduction Enhancer Market Scenario by Region

3.1 Global Viral Transduction Enhancer Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Viral Transduction Enhancer Sales by Region: 2020-2031

3.2.1 Global Viral Transduction Enhancer Sales by Region: 2020-2025

3.2.2 Global Viral Transduction Enhancer Sales by Region: 2026-2031

3.3 Global Viral Transduction Enhancer Revenue by Region: 2020-2031

3.3.1 Global Viral Transduction Enhancer Revenue by Region: 2020-2025

3.3.2 Global Viral Transduction Enhancer Revenue by Region: 2026-2031

3.4 North America Viral Transduction Enhancer Market Facts & Figures by Country

3.4.1 North America Viral Transduction Enhancer Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Viral Transduction Enhancer Sales by Country (2020-2031)

3.4.3 North America Viral Transduction Enhancer Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Viral Transduction Enhancer Market Facts & Figures by Country

3.5.1 Europe Viral Transduction Enhancer Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Viral Transduction Enhancer Sales by Country (2020-2031)

3.5.3 Europe Viral Transduction Enhancer Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Viral Transduction Enhancer Market Facts & Figures by Region

3.6.1 Asia Pacific Viral Transduction Enhancer Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Viral Transduction Enhancer Sales by Region (2020-2031)

3.6.3 Asia Pacific Viral Transduction Enhancer Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Viral Transduction Enhancer Market Facts & Figures by Country

3.7.1 Latin America Viral Transduction Enhancer Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Viral Transduction Enhancer Sales by Country (2020-2031)

3.7.3 Latin America Viral Transduction Enhancer Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Viral Transduction Enhancer Market Facts & Figures by Country

3.8.1 Middle East and Africa Viral Transduction Enhancer Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Viral Transduction Enhancer Sales by Country (2020-2031)

3.8.3 Middle East and Africa Viral Transduction Enhancer Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Viral Transduction Enhancer Sales by Type (2020-2031)

4.1.1 Global Viral Transduction Enhancer Sales by Type (2020-2025)

4.1.2 Global Viral Transduction Enhancer Sales by Type (2026-2031)

4.1.3 Global Viral Transduction Enhancer Sales Market Share by Type (2020-2031)

4.2 Global Viral Transduction Enhancer Revenue by Type (2020-2031)

4.2.1 Global Viral Transduction Enhancer Revenue by Type (2020-2025)

4.2.2 Global Viral Transduction Enhancer Revenue by Type (2026-2031)

4.2.3 Global Viral Transduction Enhancer Revenue Market Share by Type (2020-2031)

4.3 Global Viral Transduction Enhancer Price by Type (2020-2031)

5 Segment by Application

5.1 Global Viral Transduction Enhancer Sales by Application (2020-2031)

5.1.1 Global Viral Transduction Enhancer Sales by Application (2020-2025)

5.1.2 Global Viral Transduction Enhancer Sales by Application (2026-2031)

5.1.3 Global Viral Transduction Enhancer Sales Market Share by Application (2020-2031)

5.2 Global Viral Transduction Enhancer Revenue by Application (2020-2031)

5.2.1 Global Viral Transduction Enhancer Revenue by Application (2020-2025)

5.2.2 Global Viral Transduction Enhancer Revenue by Application (2026-2031)

5.2.3 Global Viral Transduction Enhancer Revenue Market Share by Application (2020-2031)

5.3 Global Viral Transduction Enhancer Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Thermo Fisher Scientific

6.1.1 Thermo Fisher Scientific Company Information

6.1.2 Thermo Fisher Scientific Description and Business Overview

6.1.3 Thermo Fisher Scientific Viral Transduction Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Thermo Fisher Scientific Viral Transduction Enhancer Product Portfolio

6.1.5 Thermo Fisher Scientific Recent Developments/Updates

6.2 Applied Biological Materials

6.2.1 Applied Biological Materials Company Information

6.2.2 Applied Biological Materials Description and Business Overview

6.2.3 Applied Biological Materials Viral Transduction Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Applied Biological Materials Viral Transduction Enhancer Product Portfolio

6.2.5 Applied Biological Materials Recent Developments/Updates

6.3 Takara Bio

6.3.1 Takara Bio Company Information

6.3.2 Takara Bio Description and Business Overview

6.3.3 Takara Bio Viral Transduction Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Takara Bio Viral Transduction Enhancer Product Portfolio

6.3.5 Takara Bio Recent Developments/Updates

6.4 OZ Biosciences

6.4.1 OZ Biosciences Company Information

6.4.2 OZ Biosciences Description and Business Overview

6.4.3 OZ Biosciences Viral Transduction Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.4.4 OZ Biosciences Viral Transduction Enhancer Product Portfolio

6.4.5 OZ Biosciences Recent Developments/Updates

6.5 Revvity

6.5.1 Revvity Company Information

6.5.2 Revvity Description and Business Overview

6.5.3 Revvity Viral Transduction Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Revvity Viral Transduction Enhancer Product Portfolio

6.5.5 Revvity Recent Developments/Updates

6.6 Bio-Techne

6.6.1 Bio-Techne Company Information

6.6.2 Bio-Techne Description and Business Overview

6.6.3 Bio-Techne Viral Transduction Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Bio-Techne Viral Transduction Enhancer Product Portfolio

6.6.5 Bio-Techne Recent Developments/Updates

6.7 Virongy

6.7.1 Virongy Company Information

6.7.2 Virongy Description and Business Overview

6.7.3 Virongy Viral Transduction Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Virongy Viral Transduction Enhancer Product Portfolio

6.7.5 Virongy Recent Developments/Updates

6.8 BPS Bioscience

6.8.1 BPS Bioscience Company Information

6.8.2 BPS Bioscience Description and Business Overview

6.8.3 BPS Bioscience Viral Transduction Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.8.4 BPS Bioscience Viral Transduction Enhancer Product Portfolio

6.8.5 BPS Bioscience Recent Developments/Updates

6.9 System Biosciences

6.9.1 System Biosciences Company Information

6.9.2 System Biosciences Description and Business Overview

6.9.3 System Biosciences Viral Transduction Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.9.4 System Biosciences Viral Transduction Enhancer Product Portfolio

6.9.5 System Biosciences Recent Developments/Updates

6.10 Miltenyi Biotec

6.10.1 Miltenyi Biotec Company Information

6.10.2 Miltenyi Biotec Description and Business Overview

6.10.3 Miltenyi Biotec Viral Transduction Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Miltenyi Biotec Viral Transduction Enhancer Product Portfolio

6.10.5 Miltenyi Biotec Recent Developments/Updates

6.11 komabiotech

6.11.1 komabiotech Company Information

6.11.2 komabiotech Description and Business Overview

6.11.3 komabiotech Viral Transduction Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.11.4 komabiotech Viral Transduction Enhancer Product Portfolio

6.11.5 komabiotech Recent Developments/Updates

6.12 ABP Biosciences

6.12.1 ABP Biosciences Company Information

6.12.2 ABP Biosciences Description and Business Overview

6.12.3 ABP Biosciences Viral Transduction Enhancer Sales, Revenue and Gross Margin (2020-2025)

6.12.4 ABP Biosciences Viral Transduction Enhancer Product Portfolio

6.12.5 ABP Biosciences Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Viral Transduction Enhancer Industry Chain Analysis

7.2 Viral Transduction Enhancer Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Viral Transduction Enhancer Production Mode & Process Analysis

7.4 Viral Transduction Enhancer Sales and Marketing

7.4.1 Viral Transduction Enhancer Sales Channels

7.4.2 Viral Transduction Enhancer Distributors

7.5 Viral Transduction Enhancer Customer Analysis

8 Viral Transduction Enhancer Market Dynamics

8.1 Viral Transduction Enhancer Industry Trends

8.2 Viral Transduction Enhancer Market Drivers

8.3 Viral Transduction Enhancer Market Challenges

8.4 Viral Transduction Enhancer Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Viral Transduction Enhancer Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Viral Transduction Enhancer Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Viral Transduction Enhancer Market Competitive Situation by Manufacturers in 2024

Table 4. Global Viral Transduction Enhancer Sales (kg) of Key Manufacturers (2020-2025)

Table 5. Global Viral Transduction Enhancer Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Viral Transduction Enhancer Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Viral Transduction Enhancer Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Viral Transduction Enhancer Average Price (US$/kg) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Viral Transduction Enhancer, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Viral Transduction Enhancer, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Viral Transduction Enhancer, Product Type & Application

Table 12. Global Key Manufacturers of Viral Transduction Enhancer, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Viral Transduction Enhancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Transduction Enhancer as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Viral Transduction Enhancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Viral Transduction Enhancer Sales by Region (2020-2025) & (kg)

Table 18. Global Viral Transduction Enhancer Sales Market Share by Region (2020-2025)

Table 19. Global Viral Transduction Enhancer Sales by Region (2026-2031) & (kg)

Table 20. Global Viral Transduction Enhancer Sales Market Share by Region (2026-2031)

Table 21. Global Viral Transduction Enhancer Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Viral Transduction Enhancer Revenue Market Share by Region (2020-2025)

Table 23. Global Viral Transduction Enhancer Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Viral Transduction Enhancer Revenue Market Share by Region (2026-2031)

Table 25. North America Viral Transduction Enhancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Viral Transduction Enhancer Sales by Country (2020-2025) & (kg)

Table 27. North America Viral Transduction Enhancer Sales by Country (2026-2031) & (kg)

Table 28. North America Viral Transduction Enhancer Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Viral Transduction Enhancer Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Viral Transduction Enhancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Viral Transduction Enhancer Sales by Country (2020-2025) & (kg)

Table 32. Europe Viral Transduction Enhancer Sales by Country (2026-2031) & (kg)

Table 33. Europe Viral Transduction Enhancer Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Viral Transduction Enhancer Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Viral Transduction Enhancer Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Viral Transduction Enhancer Sales by Region (2020-2025) & (kg)

Table 37. Asia Pacific Viral Transduction Enhancer Sales by Region (2026-2031) & (kg)

Table 38. Asia Pacific Viral Transduction Enhancer Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Viral Transduction Enhancer Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Viral Transduction Enhancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Viral Transduction Enhancer Sales by Country (2020-2025) & (kg)

Table 42. Latin America Viral Transduction Enhancer Sales by Country (2026-2031) & (kg)

Table 43. Latin America Viral Transduction Enhancer Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Viral Transduction Enhancer Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Viral Transduction Enhancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Viral Transduction Enhancer Sales by Country (2020-2025) & (kg)

Table 47. Middle East and Africa Viral Transduction Enhancer Sales by Country (2026-2031) & (kg)

Table 48. Middle East and Africa Viral Transduction Enhancer Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Viral Transduction Enhancer Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Viral Transduction Enhancer Sales (kg) by Type (2020-2025)

Table 51. Global Viral Transduction Enhancer Sales (kg) by Type (2026-2031)

Table 52. Global Viral Transduction Enhancer Sales Market Share by Type (2020-2025)

Table 53. Global Viral Transduction Enhancer Sales Market Share by Type (2026-2031)

Table 54. Global Viral Transduction Enhancer Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Viral Transduction Enhancer Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Viral Transduction Enhancer Revenue Market Share by Type (2020-2025)

Table 57. Global Viral Transduction Enhancer Revenue Market Share by Type (2026-2031)

Table 58. Global Viral Transduction Enhancer Price (US$/kg) by Type (2020-2025)

Table 59. Global Viral Transduction Enhancer Price (US$/kg) by Type (2026-2031)

Table 60. Global Viral Transduction Enhancer Sales (kg) by Application (2020-2025)

Table 61. Global Viral Transduction Enhancer Sales (kg) by Application (2026-2031)

Table 62. Global Viral Transduction Enhancer Sales Market Share by Application (2020-2025)

Table 63. Global Viral Transduction Enhancer Sales Market Share by Application (2026-2031)

Table 64. Global Viral Transduction Enhancer Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Viral Transduction Enhancer Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Viral Transduction Enhancer Revenue Market Share by Application (2020-2025)

Table 67. Global Viral Transduction Enhancer Revenue Market Share by Application (2026-2031)

Table 68. Global Viral Transduction Enhancer Price (US$/kg) by Application (2020-2025)

Table 69. Global Viral Transduction Enhancer Price (US$/kg) by Application (2026-2031)

Table 70. Thermo Fisher Scientific Company Information

Table 71. Thermo Fisher Scientific Description and Business Overview

Table 72. Thermo Fisher Scientific Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 73. Thermo Fisher Scientific Viral Transduction Enhancer Product

Table 74. Thermo Fisher Scientific Recent Developments/Updates

Table 75. Applied Biological Materials Company Information

Table 76. Applied Biological Materials Description and Business Overview

Table 77. Applied Biological Materials Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 78. Applied Biological Materials Viral Transduction Enhancer Product

Table 79. Applied Biological Materials Recent Developments/Updates

Table 80. Takara Bio Company Information

Table 81. Takara Bio Description and Business Overview

Table 82. Takara Bio Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 83. Takara Bio Viral Transduction Enhancer Product

Table 84. Takara Bio Recent Developments/Updates

Table 85. OZ Biosciences Company Information

Table 86. OZ Biosciences Description and Business Overview

Table 87. OZ Biosciences Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 88. OZ Biosciences Viral Transduction Enhancer Product

Table 89. OZ Biosciences Recent Developments/Updates

Table 90. Revvity Company Information

Table 91. Revvity Description and Business Overview

Table 92. Revvity Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 93. Revvity Viral Transduction Enhancer Product

Table 94. Revvity Recent Developments/Updates

Table 95. Bio-Techne Company Information

Table 96. Bio-Techne Description and Business Overview

Table 97. Bio-Techne Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 98. Bio-Techne Viral Transduction Enhancer Product

Table 99. Bio-Techne Recent Developments/Updates

Table 100. Virongy Company Information

Table 101. Virongy Description and Business Overview

Table 102. Virongy Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 103. Virongy Viral Transduction Enhancer Product

Table 104. Virongy Recent Developments/Updates

Table 105. BPS Bioscience Company Information

Table 106. BPS Bioscience Description and Business Overview

Table 107. BPS Bioscience Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 108. BPS Bioscience Viral Transduction Enhancer Product

Table 109. BPS Bioscience Recent Developments/Updates

Table 110. System Biosciences Company Information

Table 111. System Biosciences Description and Business Overview

Table 112. System Biosciences Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 113. System Biosciences Viral Transduction Enhancer Product

Table 114. System Biosciences Recent Developments/Updates

Table 115. Miltenyi Biotec Company Information

Table 116. Miltenyi Biotec Description and Business Overview

Table 117. Miltenyi Biotec Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 118. Miltenyi Biotec Viral Transduction Enhancer Product

Table 119. Miltenyi Biotec Recent Developments/Updates

Table 120. komabiotech Company Information

Table 121. komabiotech Description and Business Overview

Table 122. komabiotech Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 123. komabiotech Viral Transduction Enhancer Product

Table 124. komabiotech Recent Developments/Updates

Table 125. ABP Biosciences Company Information

Table 126. ABP Biosciences Description and Business Overview

Table 127. ABP Biosciences Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 128. ABP Biosciences Viral Transduction Enhancer Product

Table 129. ABP Biosciences Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Viral Transduction Enhancer Distributors List

Table 133. Viral Transduction Enhancer Customers List

Table 134. Viral Transduction Enhancer Market Trends

Table 135. Viral Transduction Enhancer Market Drivers

Table 136. Viral Transduction Enhancer Market Challenges

Table 137. Viral Transduction Enhancer Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Product Picture of Viral Transduction Enhancer

Figure 2. Global Viral Transduction Enhancer Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Viral Transduction Enhancer Market Share by Type: 2024 & 2031

Figure 4. Retrovirus (RV) Product Picture

Figure 5. Adenovirus (AdV) Product Picture

Figure 6. Adeno-associated Virus (AAV) Product Picture

Figure 7. Global Viral Transduction Enhancer Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Viral Transduction Enhancer Market Share by Application: 2024 & 2031

Figure 9. Hospitals

Figure 10. Clinical Laboratories

Figure 11. Others

Figure 12. Global Viral Transduction Enhancer Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Viral Transduction Enhancer Market Size (2020-2031) & (US$ Million)

Figure 14. Global Viral Transduction Enhancer Sales (2020-2031) & (kg)

Figure 15. Global Viral Transduction Enhancer Average Price (US$/kg) & (2020-2031)

Figure 16. Viral Transduction Enhancer Report Years Considered

Figure 17. Viral Transduction Enhancer Sales Share by Manufacturers in 2024

Figure 18. Global Viral Transduction Enhancer Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Viral Transduction Enhancer Players: Market Share by Revenue in Viral Transduction Enhancer in 2024

Figure 20. Viral Transduction Enhancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Viral Transduction Enhancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Viral Transduction Enhancer Sales Market Share by Country (2020-2031)

Figure 23. North America Viral Transduction Enhancer Revenue Market Share by Country (2020-2031)

Figure 24. United States Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Viral Transduction Enhancer Sales Market Share by Country (2020-2031)

Figure 27. Europe Viral Transduction Enhancer Revenue Market Share by Country (2020-2031)

Figure 28. Germany Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Viral Transduction Enhancer Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Viral Transduction Enhancer Revenue Market Share by Region (2020-2031)

Figure 35. China Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Viral Transduction Enhancer Sales Market Share by Country (2020-2031)

Figure 43. Latin America Viral Transduction Enhancer Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Viral Transduction Enhancer Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Viral Transduction Enhancer Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Viral Transduction Enhancer Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Viral Transduction Enhancer by Type (2020-2031)

Figure 54. Global Revenue Market Share of Viral Transduction Enhancer by Type (2020-2031)

Figure 55. Global Viral Transduction Enhancer Price (US$/kg) by Type (2020-2031)

Figure 56. Global Sales Market Share of Viral Transduction Enhancer by Application (2020-2031)

Figure 57. Global Revenue Market Share of Viral Transduction Enhancer by Application (2020-2031)

Figure 58. Global Viral Transduction Enhancer Price (US$/kg) by Application (2020-2031)

Figure 59. Viral Transduction Enhancer Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Viral Transduction Enhancer market? zhanKai

The top companies in the global Viral Transduction Enhancer market are Thermo Fisher Scientific、Applied Biological Materials、Takara Bio.

Related Reports

Global Viral Transduction Enhancer Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Viral Transduction Enhancer market is projected to grow from US$ 169 million in 2025 to US$ 241 million by 2032, at a CAGR of 5.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-17
Pages: 174
USD 4900.00
(Single User License)
Global Viral Transduction Enhancer Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Viral Transduction Enhancer market size was US$ 169 million in 2025 and is forecast to reach a readjusted size of US$ 241 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published Date: 2026-07-17
Pages: 155
USD 4250.00
(Single User License)
Viral Transduction Enhancer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Viral Transduction Enhancer was estimated to be worth US$ 169 million in 2025 and is projected to reach US$ 241 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-07-17
Pages: 147
USD 3950.00
(Single User License)
Global Viral Transduction Enhancer Market Research Report 2026
The global Viral Transduction Enhancer market was valued at US$ 169 million in 2025 and is anticipated to reach US$ 241 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-07-17
Pages: 132
USD 2900.00
(Single User License)
Global Viral Transduction Enhancer Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Viral Transduction Enhancer market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 166
USD 4900.00
(Single User License)
Global Viral Transduction Enhancer Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Viral Transduction Enhancer market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 100
USD 4250.00
(Single User License)
Viral Transduction Enhancer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Viral Transduction Enhancer was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 123
USD 3950.00
(Single User License)
Global Viral Transduction Enhancer Market Research Report 2024
A Viral Transduction Enhancer refers to a substance or method that increases the efficiency with which a virus introduces genetic material into a host cell. In gene therapy and research, viral transduction is a common technique used to deliver therapeutic genes or other genetic elements into cells. Enhancers in this context can include chemical compounds, modifications to the virus, or specific environmental conditions that improve the virus's ability to enter the host cell, thereby increasing the success rate of gene delivery and expression. These enhancers are crucial in optimizing the effectiveness of viral-based gene therapies and related biotechnological applications.
Published Date: 2024-08-24
Pages: 97
USD 2900.00
(Single User License)
Global and United States Viral Transduction Enhancer Market Report & Forecast 2024-2030
A Viral Transduction Enhancer refers to a substance or method that increases the efficiency with which a virus introduces genetic material into a host cell. In gene therapy and research, viral transduction is a common technique used to deliver therapeutic genes or other genetic elements into cells. Enhancers in this context can include chemical compounds, modifications to the virus, or specific environmental conditions that improve the virus's ability to enter the host cell, thereby increasing the success rate of gene delivery and expression. These enhancers are crucial in optimizing the effectiveness of viral-based gene therapies and related biotechnological applications.
Published Date: 2024-08-24
Pages: 123
USD 4350.00
(Single User License)
Global Viral Transduction Enhancer Market Insights, Forecast to 2030
A Viral Transduction Enhancer refers to a substance or method that increases the efficiency with which a virus introduces genetic material into a host cell. In gene therapy and research, viral transduction is a common technique used to deliver therapeutic genes or other genetic elements into cells. Enhancers in this context can include chemical compounds, modifications to the virus, or specific environmental conditions that improve the virus's ability to enter the host cell, thereby increasing the success rate of gene delivery and expression. These enhancers are crucial in optimizing the effectiveness of viral-based gene therapies and related biotechnological applications.
Published Date: 2024-08-24
Pages: 149
USD 4900.00
(Single User License)

Global Viral Transduction Enhancer Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Viral Transduction Enhancer market is projected to grow from US$ 169 million in 2025 to US$ 241 million by 2032, at a CAGR of 5.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-17
Pages: 174
USD 4900.00 (Single User License)
Global Viral Transduction Enhancer Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Viral Transduction Enhancer market size was US$ 169 million in 2025 and is forecast to reach a readjusted size of US$ 241 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published: 2026-07-17
Pages: 155
USD 4250.00 (Single User License)
Viral Transduction Enhancer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Viral Transduction Enhancer was estimated to be worth US$ 169 million in 2025 and is projected to reach US$ 241 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-07-17
Pages: 147
USD 3950.00 (Single User License)
Global Viral Transduction Enhancer Market Research Report 2026
The global Viral Transduction Enhancer market was valued at US$ 169 million in 2025 and is anticipated to reach US$ 241 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-07-17
Pages: 132
USD 2900.00 (Single User License)
Global Viral Transduction Enhancer Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Viral Transduction Enhancer market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 166
USD 4900.00 (Single User License)
Global Viral Transduction Enhancer Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Viral Transduction Enhancer market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 100
USD 4250.00 (Single User License)
Viral Transduction Enhancer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Viral Transduction Enhancer was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 123
USD 3950.00 (Single User License)
Global Viral Transduction Enhancer Market Research Report 2024
A Viral Transduction Enhancer refers to a substance or method that increases the efficiency with which a virus introduces genetic material into a host cell. In gene therapy and research, viral transduction is a common technique used to deliver therapeutic genes or other genetic elements into cells. Enhancers in this context can include chemical compounds, modifications to the virus, or specific environmental conditions that improve the virus's ability to enter the host cell, thereby increasing the success rate of gene delivery and expression. These enhancers are crucial in optimizing the effectiveness of viral-based gene therapies and related biotechnological applications.
Published: 2024-08-24
Pages: 97
USD 2900.00 (Single User License)
Global and United States Viral Transduction Enhancer Market Report & Forecast 2024-2030
A Viral Transduction Enhancer refers to a substance or method that increases the efficiency with which a virus introduces genetic material into a host cell. In gene therapy and research, viral transduction is a common technique used to deliver therapeutic genes or other genetic elements into cells. Enhancers in this context can include chemical compounds, modifications to the virus, or specific environmental conditions that improve the virus's ability to enter the host cell, thereby increasing the success rate of gene delivery and expression. These enhancers are crucial in optimizing the effectiveness of viral-based gene therapies and related biotechnological applications.
Published: 2024-08-24
Pages: 123
USD 4350.00 (Single User License)
Global Viral Transduction Enhancer Market Insights, Forecast to 2030
A Viral Transduction Enhancer refers to a substance or method that increases the efficiency with which a virus introduces genetic material into a host cell. In gene therapy and research, viral transduction is a common technique used to deliver therapeutic genes or other genetic elements into cells. Enhancers in this context can include chemical compounds, modifications to the virus, or specific environmental conditions that improve the virus's ability to enter the host cell, thereby increasing the success rate of gene delivery and expression. These enhancers are crucial in optimizing the effectiveness of viral-based gene therapies and related biotechnological applications.
Published: 2024-08-24
Pages: 149
USD 4900.00 (Single User License)